ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ САРКОПЕНИИ ПРИ МЕТАБОЛИЧЕСКИ АССОЦИИРОВАННОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
Ключевые слова:
саркопения; эпидемиология; патогенез; коморбидные состояния; инсулинорезистентность; хроническое воспалениеАннотация
Клинические исследования демонстрируют, что наличие саркопении у пациентов с МАЖБП ассоциируется с ухудшением прогноза, включая повышение риска прогрессирования фиброза печени, снижение физической активности и увеличение общей смертности. Эти данные подчеркивают необходимость комплексного подхода к диагностике и лечению, направленного на раннее выявление саркопении у пациентов с МАЖБП и разработку персонализированных стратегий терапии, учитывающих взаимное влияние этих состояний.
Библиографические ссылки
Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021 Aug;50:101238. doi: 10.1016/j.molmet.2021.101238
Zhao Q, Yin Y, Deng Y. Metabolic associated fatty liver disease and sarcopenia additively increase mortality: a real-world study. Nutr Diabetes. 2023 Nov 15;13(1):21. doi: 10.1038/s41387-023-00250-6
Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr. 2022 Jan 17;8:774030. doi: 10.3389/fnut.2021.774030. PMID: 35111794; PMCID: PMC8802760.
Gao Y, Liu D, Xiao Q, Huang S, Li L, Xie B, Zhou L, Qi Y, Liu Y. Exploration of Pathogenesis and Cutting-Edge Treatment Strategies of Sarcopenia: A Narrative Review. Clin Interv Aging. 2025 May 23;20:659-684. doi: 10.2147/CIA.S517833
Deng C, Ou Q, Ou X, Pan D. Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis. BMJ Open. 2024;14(5):e078933. Published 2024 May 6. doi:10.1136/bmjopen-2023-078933
Malik A, Javaid S, Malik MI, Qureshi S. Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis. Ann Hepatol. 2024;29(6):101544. doi:10.1016/j.aohep.2024.101544
Cai C, Song X, Chen Y, Chen X, Yu C. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Int. 2020;14(1):115-126. doi:10.1007/s12072-019-09964-1
Yu R, Shi Q, Liu L, Chen L. Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis. BMC Gastroenterol. 2018;18(1):51. Published 2018 Apr 19. doi:10.1186/s12876-018-0776-0
Rezuş E, Burlui A, Cardoneanu A, Rezuş C, Codreanu C, Pârvu M, Rusu Zota G, Tamba BI. Inactivity and Skeletal Muscle Metabolism: A Vicious Cycle in Old Age. Int J Mol Sci. 2020;21 doi: 10.3390/ijms21020592
Song E, Hwang SY, Park MJ, Jang A, Kim KJ, Yu JH, Kim NH, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi KM. Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study. Metabolism. 2023;148:155678. doi: 10.1016/j.metabol.2023.155678
Kouvari M, Polyzos SA, Chrysohoou C, Skoumas J, Pitsavos CS, Panagiotakos DB, Mantzoros CS. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study. Clin Nutr. 2022;41:1281–1289. doi: 10.1016/j.clnu.2022.03.022
Kim D, Wijarnpreecha K, Sandhu KK, Cholankeril G, Ahmed A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41:1832–1840. doi: 10.1111/liv.14852
Han E, Kim MK, Im SS, Jang BK, Kim HS. Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity. J Diabetes Complications. 2022;36:108253. doi: 10.1016/j.jdiacomp.2022.108253
Harring M, Golabi P, Paik JM, Shah D, Racila A, Cable R, Srishord M, Younossi ZM. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis. Clin Gastroenterol Hepatol. 2023;21:2876–2888.e5. doi: 10.1016/j.cgh.2023.02.013
Kong Q, Yi M, Teng F, Li H, Chen Z. Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis. J Hepatocell Carcinoma. 2023;10:1367–1377. doi: 10.2147/JHC.S418885
Sheptulina AF, Yafarova AA, Golubeva JA, Mamutova EM, Kiselev AR, Drapkina OM. Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease. J Pers Med. 2023;13 doi: 10.3390/jpm13060932
Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: interventions to counteract the ‘anabolic resistance’ of ageing. Nutr Metab (Lond). 2011;8:68
Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: interventions to counteract the ‘anabolic resistance’ of ageing. Nutr Metab (Lond). 2011;8:68.
Goodman CA. Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass. J Appl Physiol. 2019;127(2):581–590.
Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(Suppl. 1):S47–64. https://doi.org/10.1016/j.jhep.2014.12.012
Guan L, Zhang X, Tian H, Jin X, Fan H, Wang N, Sun J, Li D, Li J, Wang X, Zeng Z, Li Y. Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey. BMJ Open. 2022;12:e047588. doi: 10.1136/bmjopen-2020-047588
Campos PIC, Malachias MVB, Leopoldino AAO, Diz JBM. HEART FAILURE IN PATIENTS WITH SARCOPENIA: SYSTEMATIC REVIEW AND META-ANALYSIS. Ann Geriatr Med Res. Published online April 10, 2025. doi:10.4235/agmr.24.0186
Carvalho do Nascimento PR, Bilodeau M, Poitras S. How do we define and measure sarcopenia? A meta-analysis of observational studies. Age Ageing. 2021;50(6):1906-1913. doi:10.1093/ageing/afab148
Haas JT, Francque S, Staels B. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. Annu Rev Physiol. 2016;78:181–205. doi: 10.1146/annurev-physiol-021115-105331
Chen L, Hu Y. The correlation between serum thyroid hormone levels and hand grip among elderly male Chinese inpatients. Aging Male. 2020;23(5):928–933.
Cho Y, Park HS, Huh BW, Lee YH, Seo SH, Seo DH, Ahn SH, Hong S, Kim SH. Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2023;47:232–241. doi: 10.4093/dmj.2021.0355
Clemente MG, Mandato C, Poeta M, Vajro P. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World J Gastroenterol. 2016;22(36):8078–8093. doi: 10.3748/wjg.v22.i36.8078
Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: interventions to counteract the ‘anabolic resistance’ of ageing. Nutr Metab (Lond). 2011;8:68. doi: 10.1186/1743-7075-8-68
Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313–3327. doi: 10.1007/s00018-018-2860-6
Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063–1075. doi: 10.1016/j.jhep.2018.01.019
Арипова Н.Н., Хамраев А.А., Собирова Г.Н. Дефицит витамина Д и экзокринная недостаточность поджелудочной железы: вопросы лечебной коррекции Тошкент тиббиёт академияси ахборотномаси № 11. 2023. Б. 15-17
Бафаева З.О., Манзитова В.Ф. Использование и возможности передовых технологий в реабилитации. Тошкент тиббиёт академияси ахборотномаси № 2 2025 Б. 227-228
Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med. 2004;34(12):809–824. doi: 10.2165/00007256-200434120-00002
Jo D, Yoon G, Kim OY, Song J. A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction. Biomed Pharmacother. 2022;147:112636. doi: 10.1016/j.biopha.2022.112636.
Jogiat UM, Bédard ELR, Sasewich H, et al. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(6):2630-2636. doi:10.1002/jcsm.13082
Khadra D, Itani L, Chebaro Y, et al. Association Between Sarcopenic Obesity and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis. Curr Cardiol Rev. 2020;16(2):153-162. doi:10.2174/1573403X16666200214104122
Feng Z, Zhao F, Wang Z, Tang X, Xie Y, Qiu L. The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations. BMC Gastroenterol. 2024 Mar 15;24(1):111. doi: 10.1186/s12876-024-03192-0
